Project Grant RM1DA064527
- This is a Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The $466,500 award will fund the development and testing of "FamilyChess", a smartphone intervention to promote initiation and retention of medication for opioid use disorder (MOUD) treatment. The project will be conducted by the University of Wisconsin System over a 2-year period from September 2025...
- This Project Grant award of $840,425.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279). The funding will support research examining the impact of pre- and postnatal substance exposure, maternal distress, and related parent-child interpersonal processes on the development of adolescent risk behaviors, including substance use and delinquency. The research will leverage a...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA 93.279 Drug Use and Addiction Research Programs, provides $3,503,736 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) to develop and test a multilevel substance use disorder (SUD) and overdose prevention strategy for rural youth involved in county juvenile court systems. The project aims to collaboratively co-design the prevention strategy and an implementation...
- This $398,393 Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and test a digital implementation tool called the "Building for Implementation Tool (BUILD IT)." The goal is to increase adoption of Selected and Indicated Prevention Programs (SIPPs) for opioid use disorder by providing organizations, including those with limited resources, with an affordable alternative to...
- This federal Project Grant award of $437,250.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund a nationwide, longitudinal survey of 430 teen-parent dyads where the teen has a history of substance use and the parent uses digital location tracking (DLT) apps to monitor their teen. The study aims to characterize how and why parents use DLT, as well...
- This federal Project Grant award of $1,948,634.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and test a smartphone-based mobile health (mHealth) intervention to reduce overdose risk among people who engage in polysubstance use. The study will build on previous research findings on polysubstance use patterns to develop the "OD-CHESS" intervention by adapting an existing substance use disorder...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the U.S. Department of Health and Human Services, is intended to enhance the delivery of parenting support within a peer recovery support service model. The $452,985 award to Baystate Medical Center, Inc. in Massachusetts will be used to develop and test an implementation strategy bundle called "Relational Health Enhanced Parenting Support (RHEP)" to improve the delivery of evidence-based...
- The National Institute on Drug Abuse (NIDA) awarded a $193,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Boston Medical Center Corporation (BMC) to implement a video-coaching intervention entitled "THRIVE" to promote positive parenting behaviors for mothers with opioid use disorder (OUD). The project aims to integrate this evidence-based parenting intervention into pediatric primary care settings as a scalable model for engaging mothers...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $973,442 to The Regents of the University of California, San Francisco (UCSF) to develop and deliver a digital substance use prevention tool for foster youth. The project, titled "CASA AND FOSTRSPACE: SYSTEMS DELIVERY OF DIGITAL SUBSTANCE USE PREVENTION TOOLS TO FOSTER YOUTH," aims to address the higher rates of substance use...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,261,490 to Chestnut Health Systems Inc. to implement and evaluate strategies for scaling up the "Just Care for Families" (JCFF) multi-component intervention. The JCFF program aims to address substance use, mental health, parenting, community building, and systems navigation needs for families involved in the child welfare system due to parental opioid and methamphetamine use. The award will support a hybrid type II effectiveness-implementation trial across 9 rural Oregon counties, with 5 counties having previously implemented JCFF with developer support. The project will test the clinical outcomes of the JCFF intervention across different points of interaction with the child welfare system, as well as the implementation outcomes when JCFF is delivered with the addition of a mobile app that provides feedback to providers on parent usage. The project period runs from September 15, 2025 to May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.3m | 9/5/25 |